A University of Oxford study points to a potential early warning in routine blood work: changes over time may help doctors spot cancer before symptoms appear, even when every individual result remains within the normal range.
Doctors have traditionally focused on single abnormal results to raise the alarm. The Oxford team took a different approach, studying records from more than 275,000 people who saw their doctor for unexplained weight loss. Within six months, nearly 14,000 were diagnosed with cancer. By tracking changes in common blood markers, the researchers found 23 patterns strongly linked to later cancer diagnoses.
The Oxford study evaluated trends across 26 different standard blood tests, not just a handful of markers.
The study, published in 'PLOS Medicine', found that the direction and pace of change in blood markers mattered more than whether a single value was outside the normal range. After adjusting for age and sex, the team found that gradual shifts in white blood cell and neutrophil counts were often associated with lung cancer. Changes in red blood cell volume were linked to a higher risk of prostate cancer, as were changes in haematocrit and the platelet-to-lymphocyte ratio.
The method requires no new machines or expensive upgrades. The Oxford researchers say simple calculations, already possible in most labs, could make this kind of screening widely available. It could help primary care doctors decide which patients with vague symptoms, such as unexplained weight loss, should be referred for more advanced tests, including CT scans or endoscopies.
Unintentional weight loss is a classic example of a symptom that is hard to pin down. Doctors often have to choose between ordering costly, invasive tests and risking a missed diagnosis. The findings suggest that monitoring blood test trends could help reduce both unnecessary procedures and late cancer detection.
Information from the study published on 17 September 2026 in PLOS Medicine, some dynamic changes in blood test results were more informative for cancer risk than single abnormal values, offering a practical way to improve early detection without new laboratory equipment.
The Oxford group plans to look beyond weight loss. Next, it will study whether similar blood test patterns can help identify cancer in people with other common but vague symptoms, such as fatigue or vomiting. If so, routine blood tests could become an ongoing health record instead of a one-off check.
Turning routine blood analysis into a timeline instead of a snapshot could change how primary care handles cancer risk. Because the approach uses information already collected in standard practice, it offers a practical way to detect cancer earlier and more accurately, potentially improving outcomes for thousands of patients each year. The evidence so far points to a future of cancer screening shaped by how doctors read existing tests, rather than by new tests.
Although the Oxford study focused on the UK, its findings are relevant across Europe, including Spain, where early cancer detection is a public health priority. Bringing trend analysis into everyday practice could help Spanish doctors identify high-risk patients sooner, especially in busy clinics where resources are tight and unnecessary testing is a concern. Moving from static to dynamic interpretation of blood tests could make cancer screening more targeted and personal, helping address one of healthcare’s toughest challenges.
